Mardia Samyoung Capillary Tubes Company Ltd vs Spacenet Enterprises India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Mardia Samyoung Capillary Tubes Company Ltd is ₹ 51.94 as of 30 Oct 15:30 . The P/E Ratio of Mardia Samyoung Capillary Tubes Company Ltd changed from 0 on March 2022 to 0 on March 2026 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Spacenet Enterprises India Ltd changed from 230 on March 2022 to 10.8 on March 2026 . This represents a CAGR of -45.76% over 5 years The Market Cap of Mardia Samyoung Capillary Tubes Company Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Spacenet Enterprises India Ltd changed from ₹ 121.98 crore on March 2022 to ₹ 171.46 crore on March 2026 . This represents a CAGR of 7.05% over 5 years The revenue of Mardia Samyoung Capillary Tubes Company Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Spacenet Enterprises India Ltd for the Jun '26 is ₹ 68.73 crore as compare to the Mar '26 revenue of ₹ 45.73 crore. This represent the growth of 50.3% The ebitda of Mardia Samyoung Capillary Tubes Company Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Spacenet Enterprises India Ltd for the Jun '26 is ₹ 18.98 crore as compare to the Mar '26 ebitda of ₹ 6.62 crore. This represent the growth of 186.71% The net profit of Mardia Samyoung Capillary Tubes Company Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Spacenet Enterprises India Ltd changed from ₹ 2.57 crore to ₹ 13.76 crore over 9 quarters. This represents a CAGR of 110.79% The Dividend Payout of Mardia Samyoung Capillary Tubes Company Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Spacenet Enterprises India Ltd changed from 23.65 % on March 2026 to 23.65 % on March 2026 . This represents a CAGR of 0.00% over 1 years .

About Mardia Samyoung Capillary Tubes Company Ltd

Mardia Samyoung Capillary Tubes Company Limited, a Joint Venture between Mardia Group Companies i.e., Mardia Extrusions & Mardia Tubes and Samyoung Jung Kwan Company of South Korea was incorporated in October, 1992.
Initially, the Company was engaged in manufacture of capillary and thin-walled pipes and tubes made from brass, stainless steel, copper and other copper alloys.
The foreign collaborator holds 25% stake in the Company.
At present, the Company is engaged in manufacture of non-ferrous metals. The foreign collaborator Samyoung, S.Korea has agreed to buy 6000 tpa of the finished products of the company apart from providing financial and technical collaboration.
The company's manufacturing facility with an installed capacity of 1800 tpa is located in Silvassa.

About Spacenet Enterprises India Ltd

Spacenet Enterprises India Limited was incorporated as 'Northgate Com Tech Private Limited' on 28 May, 2010.
The name of the Company was subsequently changed to Spacenet Enterprises India Limited on 23 November, 2015.The Company is engaged in trading of commodities and providing Information technology related services.
The Company provides fast, flexible, and reliable trading solutions tailored for a wide range of commodities including gold and other agricultural or non-agricultural goods, both finished and unfinished, in full compliance with the Securities Contracts (Regulation) Act, 1956 and applicable regulations. Pursuant to a Composite Scheme of Arrangement and Amalgamation between Northgate Technologies Limited, the erstwhile Company and Green Fire Agri Commodities Private Limited in 2011-12, the entire Business Undertaking of Northgate Technologies Limited was demerged into the Company and entire business undertaking of Green Fire Agri Commodities Private Limited was merged with Northgate Technologies Limited.

FAQs for the comparison of Mardia Samyoung Capillary Tubes Company Ltd and Spacenet Enterprises India Ltd

Which company has a larger market capitalization, Mardia Samyoung Capillary Tubes Company Ltd or Spacenet Enterprises India Ltd?

Market cap of Mardia Samyoung Capillary Tubes Company Ltd is 412 Cr while Market cap of Spacenet Enterprises India Ltd is 178 Cr

What are the key factors driving the stock performance of Mardia Samyoung Capillary Tubes Company Ltd and Spacenet Enterprises India Ltd?

The stock performance of Mardia Samyoung Capillary Tubes Company Ltd and Spacenet Enterprises India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Mardia Samyoung Capillary Tubes Company Ltd and Spacenet Enterprises India Ltd?

As of November 1, 2026, the Mardia Samyoung Capillary Tubes Company Ltd stock price is INR ₹51.94. On the other hand, Spacenet Enterprises India Ltd stock price is INR ₹3.14.

How do dividend payouts of Mardia Samyoung Capillary Tubes Company Ltd and Spacenet Enterprises India Ltd compare?

To compare the dividend payouts of Mardia Samyoung Capillary Tubes Company Ltd and Spacenet Enterprises India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.